(Q34526792)

English

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

Patrick A. Baeuerle

10

object named as

Patrick A Baeuerle

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Torsten Dreier

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Grit Lorenczewski

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christian Brandl

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Patrick Hoffmann

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Uwe Syring

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Frank Hanakam

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Peter Kufer

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gert Riethmuller

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ralf Bargou

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

690-697

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Improving the efficacy of antibody-based cancer therapies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Bispecific antibodies in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

The immunological synapse.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Bispecific human IgG by design

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Bispecific and bifunctional single chain recombinant antibodies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

The role of T-cell receptor dimerization in T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Herpesvirus saimiri transformed human T cell lines: a permissive system for human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10557

21 January 2018

Identifiers

10.1002/IJC.10557

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34526792&oldid=1553431440"